Any new HIV prevention method is not meant to sit on the shelf but to be used by the people who need it to protect themselves from HIV. We have to...

We need nothing less than disruptive action to ensure everyone who wants access to affordable lenacapavir can get it.

A clinical trial at WashU Medicine shows promising results for a personalized vaccine designed to prevent recurrence in triple-negative breast...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to...

GILD's Q3 earnings and sales beat estimates on higher HIV, Veklury, oncology and liver disease drug sales. The stock is trading up.

Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

A flexible silicone ring that slowly releases antiretrovirals is one of just two long-acting HIV prevention products registered for use in South...

Encouraging findings with immunotherapy aiming at ART-free virological control A significant step towards functional cure of HIV infection HONG KONG...

Newly developed lignin-based hydrogel proves to be a promising tool for wound healing and controlled drug release, according to a new study. With...